Evaluating Transperineal Laser Ablation as a Minimally Invasive Therapy for BPH: A Systematic Review and Meta-Analysis
##semicolon##
https://doi.org/10.59188/eduvest.v5i11.51497##semicolon##
BPH##common.commaListSeparator## TPLA##common.commaListSeparator## Minimally invasive surgical therapy##common.commaListSeparator## LUTS##common.commaListSeparator## Meta-AnalysisAbstrakt
Benign prostatic hyperplasia (BPH) is a common illness in older men, marked by lower urinary tract symptoms (LUTS) that diminish quality of life. Although conventional therapies like medication and transurethral resection of the prostate (TURP) are effective, they frequently entail considerable adverse effects. Transperineal Laser Ablation (TPLA) has emerged as a viable minimally invasive surgical intervention that provides symptom alleviation with potentially reduced consequences. The objective of this study is to comprehensively assess the clinical effectiveness and safety of TPLA in the treatment of BPH through the analysis of aggregated data from previous cohort studies. A systematic review and meta-analysis were performed in accordance with PRISMA recommendations. A total of 449 people were enrolled across ten trials. The meta-analysis revealed a substantial enhancement in all evaluated outcomes following TPLA: a −58.435% decrease in IPSS (95% CI: −70.421 to −46.449), a −63.937% reduction in PVR (95% CI: −76.937 to −50.938), a +68.031% increase in Qmax (95% CI: 47.438 to 88.624), and a −27.927% decline in prostate volume (95% CI: −36.575 to −19.280). Significant heterogeneity (I² > 90%) was observed across all outcomes. Discussion: The results indicate that TPLA markedly improves both subjective symptoms and objective urine function in individuals with BPH. TPLA is a promising, minimally invasive procedure for BPH, showing significant improvements in symptom severity and urine parameters. Although existing data endorse its effectiveness and safety, forthcoming randomized controlled studies are important to validate its long-term results and define its position in clinical practice.
##submission.citations##
Aaron, L., Franco, O. E., & Hayward, S. W. (2016). Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urologic Clinics of North America, 43(3), 279–288. https://doi.org/10.1016/j.ucl.2016.04.012
Behr, A., Salleron, J., Mazeaud, C., Larose, C., Dagry, A., Balkau, B., Michiels, C., Hubert, J., & Ferriere, J. M. (2023). Comparison of surgical procedures for benign prostatic hyperplasia of medium-volume prostates: Evaluation of the causes of rehospitalization from the French National Hospital Database (PMSI-MCO). World Journal of Urology, 41(9), 2481–2488. https://doi.org/10.1007/s00345-023-04532-8
Capogrosso, P., Fallara, G., Pozzi, E., Schifano, N., Candela, L., Costa, A., Belladelli, F., Boeri, L., Cignoli, D., Gaffuri, S., Matloob, R., Montorsi, F., & Salonia, A. (2022). Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center. Minerva Urology and Nephrology, 74(4), 456–463. https://doi.org/10.23736/S2724-6051.21.04440-7
Checcucci, E., Veccia, A., De Cillis, S., Piramide, F., Volpi, G., Amparore, D., Strategia, G., Takashi, K., Chung, B. I., Autorino, R., Porpiglia, F., & Fiori, C. (2021). New ultra-minimally invasive surgical treatment for benign prostatic hyperplasia: A systematic review and analysis of comparative outcomes. European Urology Open Science, 33, 28–41. https://doi.org/10.1016/j.euros.2021.08.009
Cornu, J. N., Ahyai, S., Bachmann, A., de la Rosette, J., Gilling, P., Gratzke, C., McVary, K., Novara, G., Woo, H., & Madersbacher, S. (2015). A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: An update. European Urology, 67(6), 1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017
Elshal, A. M., Soltan, M., El-Tabey, N. A., Laymon, M., & Nabeeh, A. (2020). Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU International, 126(6), 731–738. https://doi.org/10.1111/bju.15142
Hollingsworth, J. M., & Wilt, T. J. (2014). Lower urinary tract symptoms in men. BMJ, 349, g4474. https://doi.org/10.1136/bmj.g4474
Law, Y. X. T., Chen, W. J. K., Shen, L., & Chua, W. J. (2019). Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia. Investigative and Clinical Urology, 60(5), 351–357. https://doi.org/10.4111/icu.2019.60.5.351
Magnoni, M., Berteotti, M., Ceriotti, F., Mallia, V., Vergani, V., Peretto, G., Cuko, A., Angelini, S., Salvioni, A., & Masson, S. (2017). Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. International Journal of Cardiology, 240, 25–29. https://doi.org/10.1016/j.ijcard.2017.04.027
Nguyen, D. D., Li, T., Ferreira, R., Baker Berjaoui, M., Nguyen, A. L. V., Chughtai, B., Elterman, D., Zorn, K. C., & Bhojani, N. (2024). Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer and Prostatic Diseases, 27(1), 22–28. https://doi.org/10.1038/s41391-023-00724-1
Oelke, M., Bachmann, A., Descazeaud, A., Emberton, M., Gravas, S., Michel, M. C., N'Dow, J., Nordling, J., & de la Rosette, J. J. (2013). EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology, 64(1), 118–140. https://doi.org/10.1016/j.eururo.2013.03.004
Pan, T., Li, S. Q., Dai, Y., & Qi, J. X. (2023). Observation of complications assessed by Clavien-Dindo classification in different endoscopic procedures of benign prostatic hyperplasia: An observational study. Medicine, 102(2), e32691. https://doi.org/10.1097/MD.0000000000032691
Parsons, J. K. (2010). Benign prostatic hyperplasia and male lower urinary tract symptoms: Epidemiology and risk factors. Current Bladder Dysfunction Reports, 5(4), 212–218. https://doi.org/10.1007/s11884-010-0067-2
Qian, X., Liu, H., Xu, D., Xu, L., Huang, F., He, W., & Xing, N. (2017). Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: A review of the literature and meta-analysis. The Aging Male, 20(3), 184–191. https://doi.org/10.1080/13685538.2017.1313738
Rastrelli, G., Vignozzi, L., Corona, G., & Maggi, M. (2019). Testosterone and benign prostatic hyperplasia. Sexual Medicine Reviews, 7(2), 259–271. https://doi.org/10.1016/j.sxmr.2018.10.006
Rees, J., Bultitude, M., & Challacombe, B. (2014). The management of lower urinary tract symptoms in men. BMJ, 348, g3861. https://doi.org/10.1136/bmj.g3861
Sanda, M. G., Beaty, T. H., Stutzman, R. E., Childs, B., & Walsh, P. C. (1994). Genetic susceptibility of benign prostatic hyperplasia. Journal of Urology, 152(1), 115–119. https://doi.org/10.1016/s0022-5347(17)32835-8
Schlatmann, F. W. M., van Balken, M. R., de Winter, A. F., de Jong, I. J., & Jansen, C. J. M. (2022). How do patients understand questions about lower urinary tract symptoms? A qualitative study of problems in completing urological questionnaires. International Journal of Environmental Research and Public Health, 19(15), 9650. https://doi.org/10.3390/ijerph19159650
Sessa, F., Polverino, P., Siena, G., Bisegna, C., Lo Re, M., Spatafora, P., Maggi, M., Gacci, M., Cocci, A., Imbimbo, C., & Cicione, A. (2023). Transperineal laser ablation of the prostate (TPLA) for lower urinary tract symptoms due to benign prostatic obstruction. Journal of Clinical Medicine, 12(3), 793. https://doi.org/10.3390/jcm12030793
Walmsley, K., & Kaplan, S. A. (2004). Transurethral microwave thermotherapy for benign prostate hyperplasia: Separating truth from marketing hype. Journal of Urology, 172(4), 1249–1255. https://doi.org/10.1097/01.ju.0000140194.15808.8e
Wei, J. T., Calhoun, E., & Jacobsen, S. J. (2008). Urologic diseases in America project: Benign prostatic hyperplasia. Journal of Urology, 179(5S), S75–S80. https://doi.org/10.1016/j.juro.2008.03.141
Wilt, T. J., & N'Dow, J. (2008). Benign prostatic hyperplasia. Part 2—Management. BMJ, 336(7637), 206–210. https://doi.org/10.1136/bmj.39217.532754.47
Xia, B. W., Zhao, S. C., Chen, Z. P., Chen, C., Liu, T. S., & Yang, F. (2021). Relationship between serum total testosterone and prostate volume in aging men. Scientific Reports, 11(1), 14122. https://doi.org/10.1038/s41598-021-93728-1
Yan, J., Gao, L., Xu, G., & Zhang, J. (2022). The effectiveness and safety of three surgical procedures for the treatment for benign prostatic hyperplasia: A network meta-analysis. Heliyon, 8(10), e10884. https://doi.org/10.1016/j.heliyon.2022.e10884
##submission.downloads##
Publikované
##submission.howToCite##
Číslo
Sekcia
##submission.license##
##submission.copyrightStatement##
##submission.license.cc.by-sa4.footer##
